Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
214.80    -0.20 (-0.09%)
Bid:
214.60
Ask:
215.00
Spread: 0.40 (0.186%)
Market Cap: £4.20b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Director/PDMR Shareholding

8 Sep 2025 16:50

RNS Number : 4654Y
Convatec Group PLC
08 September 2025
 

8 September 2025

Convatec Group Plc

("Convatec" or "the Company")

 

Director/PDMR Shareholding

 

 

This announcement provides information on Persons Discharging Managerial Responsibility ("PDMR") dealings under the Convatec 2017 Save as You Earn share option scheme (the "SAYE Scheme") that took place from 2022 to present.

 

Grant of SAYE options

 

On 14 July 2022, options were granted to Jonny Mason, Interim Chief Executive Officer (then Chief Financial Officer) and PDMR over 10,346 ordinary shares of 10 pence each in the Company ("Shares") at an option price of 173.97 pence per Share under the SAYE Scheme. The options became exercisable in the ordinary course from 1 September 2025.

 

On 20 July 2023, options were granted to Karim Bitar, Chief Executive Officer and PDMR over 10,253 Shares at an option price of 175.55 pence per Share under the SAYE Scheme. The options will become exercisable in the ordinary course from 1 September 2026.

 

Exercise of SAYE options

 

On 5 September 2025, Jonny Mason, exercised options over 10,346 Shares granted on 14 July 2022 under the SAYE Scheme, at an option price of 173.97 pence per Share.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

Details of the person discharging managerial responsibilities / person closely associated

 

Name

 

Jonny Mason

 

Reason for the notification

 

 

Position/status

 

Interim Chief Executive Officer and PDMR

 

Initial notification /Amendment

 

Initial notification

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Name

 

Convatec Group Plc

 

LEI

 

213800LS272L4FIDOH92

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc

 

 

Identification code

GB00BD3VFW73

 

 

Nature of the transaction

Grant of options granted under the Convatec Group Plc 2017 Save As You Earn scheme

 

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£ 1.7397

10,346

 

Aggregated information

 

 

- Aggregated volume

N/A

 

 

- Price

 

 

Date of the transaction

 

14 July 2022

 

Place of the transaction

 

Outside a trading venue

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

Nature of the transaction

Exercise of options granted under the Convatec Group Plc 2017 Save As You Earn scheme

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£ 1.7397

10,346

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

Date of the transaction

 

5 September 2025

Place of the transaction

 

Outside a trading venue

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

 

Karim Bitar

Reason for the notification

 

Position/status

 

Chief Executive Officer and PDMR

Initial notification /Amendment

 

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

 

Convatec Group Plc

LEI

 

213800LS272L4FIDOH92

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

Nature of the transaction

Grant of options granted under the Convatec Group Plc 2017 Save As You Earn scheme

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£ 1.7555

10,253

Aggregated information

- Aggregated volume

N/A

- Price

Date of the transaction

 

20 July 2023

Place of the transaction

 

Outside a trading venue

 

 

 

Contacts

The person responsible for making this announcement is James Kerton, Company Secretary, Convatec Group plc: cosec@convatec.com

 

Media: MediaRelations@convatec.com

 

Investor Relations: IR@convatec.com

 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

 

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation

 

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVEAVITIIE
Date   Source Headline
22nd Feb 202111:30 amRNSDirector Declaration
21st Dec 202011:00 amRNSDirector Declaration
30th Nov 20203:45 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:30 pmRNSTotal Voting Rights
30th Oct 202010:40 amRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
20th Oct 20204:05 pmRNSDirector/PDMR Shareholding
19th Oct 20203:30 pmRNSDirector/PDMR Shareholding
12th Oct 20202:00 pmRNSHolding(s) in Company
7th Oct 202011:50 amRNSDirector Declaration
5th Oct 20206:35 pmRNSHolding(s) in Company
29th Sep 20202:05 pmRNSScrip Dividend - Total Issued Shares
10th Sep 20201:00 pmRNSScrip Dividend - Calculation Price
28th Aug 20203:54 pmRNSDirector/PDMR Shareholding
28th Aug 20203:42 pmRNSDirector/PDMR Shareholding
11th Aug 20209:40 amRNSHolding(s) in Company
6th Aug 20207:00 amRNSInterim Results
13th Jul 202011:00 amRNSNon-Executive Director appointment
30th Jun 20207:00 amRNSBoard Committee Changes
10th Jun 202010:00 amRNSHolding(s) in Company
1st Jun 202010:45 amRNSTotal Voting Rights
29th May 202010:00 amRNSBoard Change
19th May 202010:40 amRNSDirector/PDMR Shareholding
19th May 202010:35 amRNSDirector/PDMR Shareholding
18th May 20204:30 pmRNSHolding(s) in Company
14th May 202010:45 amRNSHolding(s) in Company
11th May 20204:10 pmRNSNon-Executive Director appointment
7th May 20204:15 pmRNSResult of AGM
5th May 20202:15 pmRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSConvaTec Group Plc Q1 2020 Trading Update
28th Apr 20202:20 pmRNSScrip Dividend - Total Issued Shares
22nd Apr 20207:00 amRNSHolding(s) in Company
9th Apr 202012:30 pmRNSScrip Dividend - Calculation Price
3rd Apr 202011:00 amRNSDirector Declaration
2nd Apr 202012:45 pmRNSAnnual General Meeting Update
24th Mar 20202:20 pmRNSDirector Declaration
16th Mar 20203:40 pmRNS2019 Annual Report & Accounts and Notice of AGM
13th Mar 202011:05 amRNSDirector/PDMR Shareholding
13th Mar 202011:00 amRNSDirector/PDMR Shareholding
11th Mar 20203:50 pmRNSDirector/PDMR Shareholding
11th Mar 20203:45 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSPreliminary Results
27th Feb 202011:00 amRNSNon-Executive Director appointment
10th Jan 202012:45 pmRNSDirector/PDMR Shareholding
7th Nov 20192:00 pmRNSUpdate Statement following AGM Voting Outcome
1st Nov 201911:30 amRNSTotal Voting Rights
30th Oct 20197:00 amRNSQ3 Trading Update
21st Oct 20194:50 pmRNSDirector/PDMR Shareholding
21st Oct 20193:45 pmRNSHolding(s) in Company
14th Oct 20193:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.